Novartis Institutes for BioMedical Research

243.3k citations
3.4k papers ·

Impact in

    • Sphingolipid Metabolism and Signaling
    • Protein Structure and Dynamics
    • Receptor Mechanisms and Signaling
    • Epigenetics and DNA Methylation
  • Immunology top 5%

Papers in

    • Receptor Mechanisms and Signaling 129
    • Chemical Synthesis and Analysis 104
    • Sphingolipid Metabolism and Signaling 101

Novartis Institutes for BioMedical Research

3.2k papers receiving 223.2k citations

Peers

Novartis Institutes for BioMedical Research
Comparison fields: 5 of 234
  • Molecular Biology 113.5k
  • Immunology 25.0k
  • Biological Psychiatry 2.7k
  • Oncology 28.5k
  • Hematology 12.2k
Replace Boehringer Ingelheim (Germany) with:
Boehringer Ingelheim (Germany) Germany
Janssen (Belgium) Belgium
Bristol-Myers Squibb (Germany) Germany
Ludwig Cancer Research Switzerland
Sanofi (France) France
VIB-KU Leuven Center for Cancer Biology Belgium
Vlaams Instituut voor Biotechnologie Belgium
Max Planck Institute of Immunobiology and Epigenetics Germany
Institut Pasteur de Lille France
Merck KGaA, Darmstadt (Germany) Germany
Novartis Institutes for BioMedical Research relative to Boehringer Ingelheim (Germany) Germany Boehringer Ingelheim (Germany)'s profile →
Citations per field
00.5×1.7×
Boehringer Ingelheim (Germany) · 1×
Citations per year

Countries citing scholars working at Novartis Institutes for BioMedical Research

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis Institutes for BioMedical Research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis Institutes for BioMedical Research with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis Institutes for BioMedical Research more than expected).

Fields of papers published by authors at Novartis Institutes for BioMedical Research

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novartis Institutes for BioMedical Research at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis Institutes for BioMedical Research at the time of their publication.

About Novartis Institutes for BioMedical Research

In recent decades, authors affiliated with Novartis Institutes for BioMedical Research have published 3.4k papers, which have received a total of 243.3k indexed citations . Scholars at this organization have produced 1.6k papers in Molecular Biology, 417 papers in Immunology, 444 papers in Oncology, 190 papers in Hematology and 271 papers in Cellular and Molecular Neuroscience on the topics of Computational Drug Discovery Methods (244 papers), Monoclonal and Polyclonal Antibodies Research (139 papers), Receptor Mechanisms and Signaling (129 papers), Neuroscience and Neuropharmacology Research (115 papers), Alzheimer's disease research and treatments (109 papers), Chemical Synthesis and Analysis (104 papers), Sphingolipid Metabolism and Signaling (101 papers) and Chronic Myeloid Leukemia Treatments (95 papers). Their work is cited by papers focused on Molecular Biology (113.5k citations), Immunology (25.0k citations), Biological Psychiatry (2.7k citations), Oncology (28.5k citations) and Hematology (12.2k citations). Authors at Novartis Institutes for BioMedical Research collaborate with scholars in Switzerland, United States and Germany and have published in prestigious journals including Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, PLoS ONE, Blood and ChemMedChem. Some of Novartis Institutes for BioMedical Research's most productive authors include Romain M. Wolf, David Andrew Case, Junmei Wang, Peter A. Kollman, James W. Caldwell, Peter F. Ertl, Volker Brinkmann, Heidi A. Lane, Matthias Staufenbiel and Michaela Kneissel.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact